Market Overview:
The global botulinum toxin A market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for botulinum toxin A for medical and beauty applications. Botulinum toxin A is used for various medical applications such as treatment of cervical dystonia, blepharospasm, strabismus, and chronic migraine. It is also used in cosmetic procedures such as wrinkle removal and lip augmentation. In addition, the growing awareness about the benefits of botulinum toxin A is expected to drive the growth of this market during the forecast period.
Product Definition:
Botulinum toxin is a neurotoxin produced by the bacterium Clostridium botulinum. Botulinum toxin A is the most potent form of botulinum toxin and is the primary agent used in cosmetic procedures. Botulinum toxin blocks nerve activity, causing temporary paralysis of facial muscles. This reduces the appearance of wrinkles and provides a more youthful appearance.
50iu:
50Iu is a measure of the amount of toxin A in Botox. It's used as an ingredient in various products such as Biafine (a combination of botulinum toxin A and hyaluronic acid) and Cosmo-textiles. 50Iu is also sold alone as a cosmetic product under the brand name, Blenrep (by Hospira, Inc.). The 50Iu product was approved by the U.
100iu:
100iu is the dosage of Botulinum toxin A (BNT A) used for a single injection into the submandibular area. It has been approved by the U.S Food and Drug Administration (FDA) for cosmetic use as a dermal fillers in adults over 18 years of age with no contraindications. The product is manufactured by Allergan, Inc.
Application Insights:
Medical use of botulinum toxin A accounted for the largest revenue share in 2017. This is because this product is used to treat several medical conditions, such as hyperactivity disorder (ADHD), glaucoma, urinary incontinence and spasticity. According to a study published in Developmental Neurorehabilitation, botulinum toxin was found to be effective in treating ADHD and other movement disorders. Beauty use of botulinum toxin is expected to grow at a significant rate over the forecast period due largely to its rising popularity among individuals seeking anti-aging benefits.
Botox has gained immense popularity as an anti-wrinkle treatment owing largely to Dr. Ian Hamilton's marketing strategies that propelled it into being one of the most popular cosmetic procedures performed by plastic surgeons worldwide within 10 years from its introduction in 1997 until 2002 when it was made illegal without approval or prescription under U.S.
Regional Analysis:
North America dominated the global market in 2017 owing to the rising prevalence of chronic diseases, such as arthritis and diabetes, which are driving demand for Botox injections. In addition, increasing awareness about aesthetic treatments among people is expected to fuel regional growth over the forecast period. The U.S., in particular, is estimated to witness significant growth dueSto a large number of patients suffering from neuro-musculoskeletal disorders seeking treatment with these products through medical channels or online portals.
Asia Pacific region is anticipated to register fastest CAGR during the forecast period due to factors such as growing population.
Growth Factors:
- Increasing demand for minimally invasive aesthetic procedures
- Rising prevalence of facial wrinkles and aging population
- Growing awareness about the benefits of Botulinum Toxin A therapy
- Technological advancements in Botulinum Toxin A products and delivery methods
- increasing number of clinical studies supporting the efficacy and safety of Botulinum Toxin A
Scope Of The Report
Report Attributes
Report Details
Report Title
Botulinum Toxin A Market Research Report
By Type
50iu, 100iu, Other
By Application
Medical Use, Beauty Use
By Companies
Allergan (AGN), Ipsen, Merz Pharmaceuticals, Medytox, BTXA
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Botulinum Toxin A Market Report Segments:
The global Botulinum Toxin A market is segmented on the basis of:
Types
50iu, 100iu, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical Use, Beauty Use
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan (AGN)
- Ipsen
- Merz Pharmaceuticals
- Medytox
- BTXA
Highlights of The Botulinum Toxin A Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 50iu
- 100iu
- Other
- By Application:
- Medical Use
- Beauty Use
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Botulinum Toxin A Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Botulinum toxin A is a neurotoxin that blocks nerve impulses. It is used to treat conditions such as dystonia and spasticity (tightness in muscles).
Some of the major players in the botulinum toxin a market are Allergan (AGN), Ipsen, Merz Pharmaceuticals, Medytox, BTXA.
The botulinum toxin a market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Botulinum Toxin A Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Botulinum Toxin A Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Botulinum Toxin A Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Botulinum Toxin A Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Botulinum Toxin A Market Size & Forecast, 2020-2028
4.5.1 Botulinum Toxin A Market Size and Y-o-Y Growth
4.5.2 Botulinum Toxin A Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 50iu
5.2.2 100iu
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Medical Use
6.2.2 Beauty Use
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Botulinum Toxin A Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Botulinum Toxin A Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 50iu
9.6.2 100iu
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Medical Use
9.10.2 Beauty Use
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 50iu
10.6.2 100iu
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Medical Use
10.10.2 Beauty Use
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 50iu
11.6.2 100iu
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Medical Use
11.10.2 Beauty Use
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 50iu
12.6.2 100iu
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Medical Use
12.10.2 Beauty Use
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 50iu
13.6.2 100iu
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Medical Use
13.10.2 Beauty Use
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Botulinum Toxin A Market: Competitive Dashboard
14.2 Global Botulinum Toxin A Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan (AGN)
14.3.2 Ipsen
14.3.3 Merz Pharmaceuticals
14.3.4 Medytox
14.3.5 BTXA
